Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Singapore Institute of Advanced Medicine Holdings Ltd. reported a 3% increase in revenue to $16.65 million for the year ending June 2024, with a significant boost in their Radiation Therapy and Medical Oncology Services segment. The company’s innovative use of the Varian ProBeam Compact proton therapy system, operational since June 2023, is seen as a key driver of this growth. Despite a loss of $37.4 million, the firm remains at the forefront of cutting-edge cancer treatment technologies.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money